Authors



Sandra Hanna, PharmD candidate

Latest:

Entyvio by Takeda Pharmaceuticals

Entyvio, manufactured by Takeda Pharmaceuticals, was approved in May 2014 for the treatment of adult patients with moderate to severe ulcerative colitis or Crohn's disease.



Russ Procopio, MBA, BS

Latest:

LTC Pharmacists Drive Positive Clinical Outcomes

Study also highlights transitions-of-care programs that help patients avoid ED visits or acute care stays.


Ronelle E. Stevens, PharmD RPh, CACP

Latest:

Patient-Centered Care: Give Patients a Shovel

With the New Year approaching, let's resolve to decrease some of the difficulty with anticoagulant medications by welcoming patients and technology into the patient counseling dialogue.


Shelby Leheny, PharmD

Latest:

Counsel Patients About Diet and Nutrition

This therapy is critical for the treatment of common disease states, including diabetes.


Anthony Palmieri, RPh, PharmD

Latest:

Trends in Medication Utilization and the Cost of Treatment for Gout

With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.


Eunice O. Ansah, MD

Latest:

Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus

In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.


Patrick Lefebvre, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Lee Feigert, PharmD, MSPBA

Latest:

Co-pay Accumulator Programs: Behind the Controversy

With ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.


PRNewswire

Latest:

Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors

Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.


Jeannie Ong, PharmD

Latest:

Adult Immunizations: Are Your Patients Up-to-Date?

In the health-system setting, pharmacists must often prioritize their attention to treating the most acute medical condition a patient presents with; however, it is important to also consider opportunities to prevent disease.



Sally Rafie, PharmD, BCPS, NCMP

Latest:

Pharmacy Best Practices for Contraceptive Care During COVID-19

It’s important that patients understand how their pharmacy can continue to meet their contraceptive needs during the coronavirus disease 2019 (COVID-19) pandemic.


Richard A. Zabinski, PharmD

Latest:

A Linezolid Prior Authorization Program: Clinical and Economic Outcomes

This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.



Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP

Latest:

Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonist

Ninety percent of diabetes cases are type 2, which is a major cause of morbidity and mortality.


Aneh Chumbow, PharmD Candidate

Latest:

Health Technology and the Rise of the E-Patient

Technology has become an essential part of health care.


Zachary Yuschock, PharmD Candidate

Latest:

Boehringer Ingelheim Pharmaceuticals' Pradaxa

Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.


Emily Woulfe, PharmD Candidate

Latest:

New Antimicrobials Expand Treatment Options

Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections


Chigo Oguh, PharmD Candidate

Latest:

Taking Home Gold and the DC Public Health Case Challenge

Each year, the National Academy of Medicine hosts its DC Public Health Case Challenge to promote interdisciplinary, problem-based learning that focuses on an important public health issue facing the Washington, DC community



Ron Lanton, Esq

Latest:

Three Current Policy Discussions Influencing Cancer Drug Development

Despite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.




Mary-Haston Vest, PharmD, MS

Latest:

Securing Specialty Oncology Contracts in a Data-Driven World

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.



Jennifer Gershman, PharmD, CPh, PACS

Latest:

Pharmacists Play an Important Role in Nutrition Education

Educating patients about the nutrition facts label and integrating food pharmacies are examples of pharmacist opportunities.



Bethany Spadaro, RPh, CDE, BCGP

Latest:

Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient Care

As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.